Drug Research

Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient's life? Adding real-world data to the standard equation in order to provide a more focused...

Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies, pharmaceutical companies can streamline processes, reduce costs, and enhance the accuracy and speed of drug...

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug (IND) submissions. By integrating artificial intelligence (AI) into their processes, Lonza has been able to significantly reduce the time...

Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and some vaccines are largely administered via injection or by infusion. These methods can often...

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the increasing significance of technology like pharmacogenomics, digital therapies, and artificial intelligence are what propel activity....

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical business new ways to make effective drugs more quickly. In the past, most drugs were put together using alkyl building...

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in the supply of toxicological data to support INDs for novel therapies and, therefore, delivery of FIH studies, as a result...